Ken Herrmann
@ProfKHerrmann
Followers
1K
Following
3K
Media
61
Statuses
711
Nuc Med - Theranostics - Innovation. Embracing Change.
Joined April 2022
RT @DrMHofman: Finally, a killer application for Y-90 FAPI theranostics? . Near complete metabolic responses in 3 patients with treatment r….
0
36
0
RT @JournalofNucMed: SNMMI Annual Meeting Flashback: Johannes Czernin and Richard Wahl discuss trending topics in nuclear medicine. https:/….
0
5
0
RT @APCCC_Lugano: A warm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 👉REGISTER HERE: .
0
19
0
RT @JournalofNucMed: ¹⁸F-CTT1057 is effective in detecting PSMA-positive lesions, with high patient-level sensitivity and region-level spec….
0
4
0
RT @CzerninJohannes: JNM Editors’ Choice Awards for 2024 | Journal of Nuclear Medicine
jnm.snmjournals.org
As in years past, it is a true pleasure for me, as editor-in-chief of The Journal of Nuclear Medicine ( JNM ), to join with our associate editors in selecting the most outstanding contributions to...
0
2
0
RT @CzerninJohannes: Summary: Appropriate Use Criteria for 18F-FDG PET/CT for Initial Staging of Malignant Disease | Journal of Nuclear Med….
0
3
0
RT @JournalofNucMed: The current state of GRPR-targeted theranostics: from bench to bedside. #NuclearMedicine #The….
0
5
0
RT @JournalofNucMed: Routine dosimetry: Proceed with caution. #NuclearMedicine #Dosimetry #RPTherapy @ProfKHerrman….
0
2
0
RT @GGiannarini: @EUplatinum Proud to be part of the family! @Albert0Briganti @LauraBukavinaMD @ChapinMD @MikkelFode @spsutkaMD @montypal @….
0
5
0
RT @JournalofNucMed: Continuing Education: Approaches to imaging immune activation using PET. #PETscan #NuclearMed….
0
9
0
RT @onkowissen: Verpasst? Kein Problem! Die wichtigsten Erkenntnisse vom #ASCO25 gibt’s jetzt als Video on demand auf onkowissenTV ➡️ https….
0
4
0
RT @JournalofNucMed: EDA-FN imaging with 89Zr-DFO-F8 exhibited powerful tumor delineation in preclinical triple-negative breast cancer mode….
0
4
0
RT @JournalofNucMed: 2024 SNMMI Highlights Lecture: Cardiovascular Sciences. #NuclearMedicine #Cardiology #Medical….
0
4
0
RT @OncoAlert: Dear Colleagues at #ASCO25.As we gear up for an Exciting day of GU oncology here in Chicago, A warm invite from our partners….
0
16
0
RT @OncoAlert: Dear Colleagues at #ASCO25.A warm invite to Join us in LuganoSwitzerland for the Advanced Prostate Cancer Consensus Conferen….
0
10
0
RT @JournalofNucMed: Discussions with Leaders: John Babich, PhD, talks about new approaches to radiopharmaceutical development. https://t.c….
0
3
0
RT @oncodaily: SBRT Safe for Oligometastases in Breast, Prostate, Colorectal - @piet_ost . #OncoDaily #Oncology #C….
0
5
0
RT @APCCC_Lugano: Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Mo….
0
23
0
RT @CzerninJohannes: Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update | Journal of….
ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO...
0
2
0
RT @JournalofNucMed: Instant single-time-point image-based dosimetry paves the way for improved patient care by ensuring dosimetry assessme….
0
7
0